Adaptive Designs in Clinical Trials
08 Apr 2013 - 09 Apr 2013 - London, UK
Clinical trials run by pharmaceutical and biotech companies have undergone major changes, implementing adaptive designs to tailor a trial. Reduction in costs and timings of early phase clinical trials can mean lower recruitment of patients and improve the overall clinical accuracy. Successful implementation of adaptive designs into a trial however requires unparalleled coordination between clinicians, trial managers, statisticians and those involved in external and internal regulation.
Our expert speakers are widely regarded as industry leaders - hear through case studies how all sizes of pharma companies have successfully implemented trials incorporating adaptive designs. This conference - the only in Europe to focus specifically on adaptive designs- will provide you with new intelligence on internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.
Adaptive Designs in Clinical Trials 2013 aims to show you how you can quickly and accurately implement an adaptive design clinical trial for your drug development - from initial processes in managing trials to choosing the right time to implement change.